Astellas

News

Astellas scores first US blood cancer approval with Xospata

The FDA has approved Astellas’ Xospata for certain patients with acute myeloid leukaemia – the company’s first drug approved in blood cancer.

Partner Content

Partner Content

Corporate Communications chief of Astellas, Jo Taylor moves ...

Jo Taylor moves to Cello Health Communications

News

Mature Woman Experiencing Hot Flush From Menopause

UK's KaNDy Therapeutics funds mid-stage trial of HRT 'replac...

Biotech hopes for IPO or big pharma deal to fund phase 3

News

Astellas buys eye gene therapy biotech Quethera for $109m

Japanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorde

News

Seattle Genetics and Astellas gain Breakthrough Designation ...

The FDA has granted Breakthrough Therapy Designation to enfortumab vedotin, an antibody-drug conjugate (ADC) being developed by Seattle Genetics and Astellas.

News

Wayward Astellas comes close to UK industry expulsion

Astellas has failed to heed warnings about not following the UK pharma industry code, and has only narrowly avoided being expelled from industry membership.

Astellas scores first US blood cancer approval with Xospata

Corporate Communications chief of Astellas, Jo Taylor moves ...

UK's KaNDy Therapeutics funds mid-stage trial of HRT 'replac...

Astellas buys eye gene therapy biotech Quethera for $109m

Seattle Genetics and Astellas gain Breakthrough Designation ...

Wayward Astellas comes close to UK industry expulsion

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Astellas

Editor's Picks